Literature DB >> 15933262

Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis.

Sami Soljanlahti1, Taina Autti, Kirsi Lauerma, Raili Raininko, Pekka Keto, Hannu Turtola, Alpo F Vuorio.   

Abstract

BACKGROUND AND
PURPOSE: To correlate known vascular disease risk factors and the signs of extracranial and intracranial changes of vascular origin in young patients with heterozygous familial hypercholesterolemia (FH).
METHODS: 39 DNA test-verified heterozygous FH North Karelian patients (FH-NK), aged 6 to 48, 28 of them treated with statins, and 25 healthy controls underwent brain magnetic resonance imaging (MRI) and carotid ultrasound.
RESULTS: Common carotid intima-media thickness was significantly greater in the patients (P=0.005). MR angiography showed no pathological changes, other than 1 incidental aneurysm. The number and size of white matter hyperintensities on T2-weighted MR images, considered as markers of microvascular alterations, did not differ between patients and controls.
CONCLUSIONS: FH-NK patients treated with statins seem to be at no increased risk for brain infarcts or other brain lesions of vascular origin when younger than age 50.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933262     DOI: 10.1161/01.STR.0000169920.64180.fa

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Intraparenchymal haematoma related to true middle meningeal artery aneurysm: a case report.

Authors:  Cetin Akyol; Erhan Turkoglu; Burak Kazancı; Hakan Seckin; Hayri Kertmen; Murad Bavbek
Journal:  BMJ Case Rep       Date:  2009-09-01

Review 2.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

3.  Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.

Authors:  Jordi Jimenez-Conde; Alessandro Biffi; Rosanna Rahman; Allison Kanakis; Christi Butler; Shruti Sonni; Efi Massasa; Lisa Cloonan; Aaron Gilson; Karen Capozzo; Lynelle Cortellini; Angel Ois; Elisa Cuadrado-Godia; Ana Rodriguez-Campello; Karen L Furie; Jaume Roquer; Jonathan Rosand; Natalia S Rost
Journal:  Stroke       Date:  2010-02-04       Impact factor: 7.914

4.  Distribution of ABO blood groups in the patients with intracranial aneurysm and association of different risk factors with particular blood type.

Authors:  Shyamal Chandra Bir; Papireddy Bollam; Anil Nanda
Journal:  Asian J Neurosurg       Date:  2015 Jul-Sep

5.  Association between Low-density lipoprotein cholesterol and occipital periventricular hyperintensities in a group of Chinese patients: an observational study.

Authors:  Dazhi Duan; Lin Shen; Chun Cui; Tongsheng Shu; Jian Zheng
Journal:  Lipids Health Dis       Date:  2017-02-27       Impact factor: 3.876

6.  High Prevalence of Cerebral Small Vessel Disease on 7T Magnetic Resonance Imaging in Familial Hypercholesterolemia.

Authors:  Yusuke Todate; Ikuko Uwano; Satoshi Yashiro; Ai Chida; Yutaka Hasegawa; Tomoyasu Oda; Kan Nagasawa; Hiroyuki Honma; Makoto Sasaki; Yasushi Ishigaki
Journal:  J Atheroscler Thromb       Date:  2019-03-15       Impact factor: 4.928

7.  Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke.

Authors:  Alpo Vuorio; Markku Kaste; Petri T Kovanen
Journal:  eNeurologicalSci       Date:  2021-04-27

8.  Compliance of the aorta in two diseases affecting vascular elasticity, familial hypercholesterolemia and diabetes: a MRI study.

Authors:  Sami Soljanlahti; Taina Autti; Laura Hyttinen; Alpo F Vuorio; Pekka Keto; Kirsi Lauerma
Journal:  Vasc Health Risk Manag       Date:  2008

9.  MRI at 3 Tesla detects no evidence for ischemic brain damage in intensively treated patients with homozygous familial hypercholesterolemia.

Authors:  Stephan A Schmitz; Declan P O'Regan; Julie Fitzpatrick; Clare Neuwirth; Elizabeth Potter; Isabella Tosi; Joseph V Hajnal; Rossi P Naoumova
Journal:  Neuroradiology       Date:  2007-07-21       Impact factor: 2.804

10.  Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI.

Authors:  Sami Soljanlahti; Taina Autti; Alpo F Vuorio; Pekka Keto; Hannu Turtola; Kirsi Lauerma
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.